Grg23 epsp synthases: compositions and methods of use

ABSTRACT

Compositions and methods for conferring herbicide resistance or tolerance to bacteria, plants, plant cells, tissues and seeds are provided. Compositions include polynucleotides encoding herbicide resistance or tolerance polypeptides, vectors comprising those polynucleotides, and host cells comprising the vectors. The nucleotide sequences of the invention can be used in DNA constructs or expression cassettes for transformation and expression in organisms, including microorganisms and plants. Compositions also include transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated polynucleotides encoding glyphosate resistance or tolerance polypeptides are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for isolated polynucleotides containing nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO:9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, or 35, or the nucleotide sequence set forth in SEQ ID NO:6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, or 34.

CROSS REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. patent application Ser. No.12/856,082, filed Aug. 13, 2010, which is a divisional of U.S. patentapplication Ser. No. 11/943,801, filed Nov. 21, 2007, now U.S. Pat. No.7,834,249, which claims the benefit of U.S. Provisional Application Ser.Nos. 60/861,455, filed Nov. 29, 2006; 60/872,200, filed Dec. 1, 2006;and 60/972,502, filed Sep. 14, 2007, the contents of which are hereinincorporated by reference in their entirety.

REFERENCE TO SEQUENCE LISTING SUBMITTED ELECTRONICALLY

The official copy of the sequence listing is submitted electronicallyvia EFS-Web as an ASCII formatted sequence listing with a file named“049US03D03NSEQLIST.txt”, created on Apr. 26, 2013, and having a size of151,000 bytes and is filed concurrently with the specification. Thesequence listing contained in this ASCII formatted document is part ofthe specification and is herein incorporated by reference in itsentirety.

FIELD OF THE INVENTION

This invention relates to plant molecular biology, particularly novelEPSP synthase polypeptides that confer improved resistance or toleranceto the herbicide glyphosate.

BACKGROUND OF THE INVENTION

N-phosphonomethylglycine, commonly referred to as glyphosate, is animportant agronomic chemical. Glyphosate inhibits the enzyme thatconverts phosphoenolpyruvic acid (PEP) and 3-phosphoshikimic acid (S3P)to 5-enolpyruvyl-3-phosphoshikimic acid. Inhibition of this enzyme(5-enolpyruvylshikimate-3-phosphate synthase; referred to herein as“EPSP synthase”, or “EPSPS”) kills plant cells by shutting down theshikimate pathway, thereby inhibiting aromatic amino acid biosynthesis.

Since glyphosate-class herbicides inhibit aromatic amino acidbiosynthesis, they not only kill plant cells, but are also toxic tobacterial cells. Glyphosate inhibits many bacterial EPSP synthases, andthus is toxic to these bacteria. However, certain bacterial EPSPsynthases have a high tolerance to glyphosate.

Plant cells resistant to glyphosate toxicity can be produced bytransforming plant cells to express glyphosate-resistant bacterial EPSPsynthases. Notably, the bacterial gene from Agrobacterium tumefaciensstrain CP4 has been used to confer herbicide resistance on plant cellsfollowing expression in plants. A mutated EPSP synthase from Salmonellatyphimurium strain CT7 confers glyphosate resistance in bacterial cells,and confers glyphosate resistance on plant cells (U.S. Pat. Nos.4,535,060; 4,769,061; and 5,094,945).

U.S. Pat. No. 6,040,497 reports mutant maize EPSP synthase enzymeshaving substitutions of threonine to isoleucine at position 102 andproline to serine at position 106 (the “TIPS” mutation). Suchalterations confer glyphosate resistance upon the maize enzyme. Amutated EPSP synthase from Salmonella typhimurium strain CT7 confersglyphosate resistance in bacterial cells, and is reported to conferglyphosate resistance upon plant cells (U.S. Pat. Nos. 4,535,060;4,769,061; and 5,094,945). He et al. ((2001) Biochim et Biophysica Acta1568:1-6) have developed EPSP synthases with increased glyphosatetolerance by mutagenesis and recombination between the E. coli andSalmonella typhimurium EPSP synthase genes, and suggest that mutationsat position 42 (T42M) and position 230 (Q230K) are likely responsiblefor the observed resistance. Subsequent work (He et al. (2003) Biosci.Biotech. Biochem. 67:1405-1409) shows that the T42M mutation (threonineto methionine) is sufficient to improve tolerance of both the E. coliand Salmonella typhimurium enzymes. Due to the many advantages herbicideresistance plants provide, herbicide resistance genes improvedglyphosate resistance activity are desirable.

An alternate method for mutagenesis is the “permutational mutagenesis”method described in U.S. patent application Ser. No. 11/762,580, filedJun. 13, 2007.

SUMMARY OF INVENTION

Compositions and methods for conferring resistance or tolerance to areprovided. Compositions include EPSP synthase enzymes that are resistantto glyphosate herbicide, and nucleic acid molecules encoding suchenzymes, vectors comprising those nucleic acid molecules, and host cellscomprising the vectors. The compositions include nucleic acid moleculesencoding herbicide resistance polypeptides, including those encodingpolypeptides comprising SEQ ID NO:9, 11, 13, 15, 17, 19, 21, 23, 25, 27,29, 31, 33, or 35, as well as the polynucleotide sequences of SEQ IDNO:6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, or 34. Thecoding sequences can be used in DNA constructs or expression cassettesfor transformation and expression in organisms, including microorganismsand plants. Compositions also comprise transformed bacteria, plants,plant cells, tissues, and seeds that are glyphosate resistant by theintroduction of the compositions of the invention into the genome of theorganism. Where the organism is a plant, the introduction of thesequence allows for glyphosate containing herbicides to be applied toplants to selectively kill glyphosate sensitive weeds or otheruntransformed plants, but not the transformed organism. The sequencescan additionally be used a marker for selection of plant cells growingunder glyphosate conditions.

Methods for identifying an EPSP synthase enzyme with glyphosateresistance activity are additionally provided. The methods compriseidentifying additional EPSP synthase sequences that are resistant toglyphosate based on the presence of the domain of the invention.

DESCRIPTION OF FIGURES

FIG. 1 demonstrates the enzymatic activity of GRG23(ace1) (“M5”; SEQ IDNO:10) compared to wild type GRG23 (“WTGRG23”; SEQ ID NO:2) at 37° C.for 0 to 25 hours.

FIG. 2 shows the resistance of GRG23 and several variants to glyphosate,expressed as the inhibition constant, or K_(i)

FIG. 3 shows the half life of GRG23 and GRG23 variants at 37° C.

DETAILED DESCRIPTION OF THE INVENTION

The present inventions now will be described more fully hereinafter withreference to the accompanying drawings, in which some, but not allembodiments of the inventions are shown. Indeed, these inventions may beembodied in many different forms and should not be construed as limitedto the embodiments set forth herein; rather, these embodiments areprovided so that this disclosure will satisfy applicable legalrequirements Like numbers refer to like elements throughout.

Many modifications and other embodiments of the inventions set forthherein will come to mind to one skilled in the art to which theseinventions pertain having the benefit of the teachings presented in theforegoing descriptions and the associated drawings. Therefore, it is tobe understood that the inventions are not to be limited to the specificembodiments disclosed and that modifications and other embodiments areintended to be included within the scope of the appended claims.Although specific terms are employed herein, they are used in a genericand descriptive sense only and not for purposes of limitation.

The present invention is drawn to compositions and methods forregulating herbicide resistance in organisms, particularly in plants orplant cells. The methods involve transforming organisms with nucleotidesequences encoding the glyphosate resistance gene of the invention.

The nucleotide sequences of the invention are useful for preparingplants that show increased tolerance to the herbicide glyphosate. Thus,by “glyphosate resistance” or “glyphosate tolerance” gene of theinvention is intended the nucleotide sequence set forth in SEQ ID NO:6,8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, or 34, and fragmentsand variants thereof that encode a glyphosate resistance or tolerancepolypeptide. Likewise, a “glyphosate resistance” or “glyphosatetolerance” polypeptide of the invention is a polypeptide having theamino acid sequence set forth in SEQ ID NO:9, 11, 13, 15, 17, 19, 21,23, 25, 27, 29, 31, 33, or 35, and fragments and variants thereof, thatconfer glyphosate resistance or tolerance to a host cell.

A. Isolated Polynucleotides, and Variants and Fragments Thereof.

In some embodiments, the present invention comprises isolated,recombinant, or purified polynucleotides. An “isolated” or “purified”polynucleotide or polypeptide, or biologically active portion thereof,is substantially free of other cellular material, or culture medium whenproduced by recombinant techniques, or substantially free of chemicalprecursors or other chemicals when chemically synthesized. By“biologically active” is intended to possess the desired biologicalactivity of the native polypeptide, that is, retain herbicide resistanceactivity. An “isolated” polynucleotide may be free of sequences (forexample, protein encoding sequences) that naturally flank the nucleicacid (i.e., sequences located at the 5′ and 3′ ends of the nucleic acid)in the genomic DNA of the organism from which the polynucleotide isderived. For purposes of the invention, “isolated” when used to refer topolynucleotides excludes isolated chromosomes. For example, in variousembodiments, the isolated glyphosate resistance-encoding polynucleotidecan contain less than about 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb, or 0.1kb of nucleotide sequence that naturally flanks the polynucleotide ingenomic DNA of the cell from which the polynucleotide is derived.

Polynucleotides of the invention include those that encodeglyphosate-resistant polypeptides comprising SEQ ID NO:9, 11, 13, 15,17, 19, 21, 23, 25, 27, 29, 31, 33, or 35, as well as the polynucleotidesequences of SEQ ID NO:6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30,32, or 34.

By “glyphosate” is intended any herbicidal form ofN-phosphonomethylglycine (including any salt thereof) and other formsthat result in the production of the glyphosate anion in planta. An“herbicide resistance protein” or a protein resulting from expression ofan “herbicide resistance-encoding nucleic acid molecule” includesproteins that confer upon a cell the ability to tolerate a higherconcentration of an herbicide than cells that do not express theprotein, or to tolerate a certain concentration of an herbicide for alonger time than cells that do not express the protein. A “glyphosateresistance protein” includes a protein that confers upon a cell theability to tolerate a higher concentration of glyphosate than cells thatdo not express the protein, or to tolerate a certain concentration ofglyphosate for a longer period of time than cells that do not expressthe protein. By “tolerate” or “tolerance” is intended either to survive,or to carry out essential cellular functions such as protein synthesisand respiration in a manner that is not readily discernable fromuntreated cells.

The present invention further contemplates variants and fragments of thepolynucleotides described herein. A “fragment” of a polynucleotide mayencode a biologically active portion of a polypeptide, or it may be afragment that can be used as a hybridization probe or PCR primer usingmethods disclosed elsewhere herein. Polynucleotides that are fragmentsof a polynucleotide comprise at least about 15, 20, 50, 75, 100, 200,300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950,1000, 1050, 1100, 1150, 1200, 1250, 1300, 1350, 1400, 1450, 1500, 1550,1600, 1650, 1700, 1750, 1800, 1850, 1900, 1950 contiguous nucleotides,or up to the number of nucleotides present in a full-lengthpolynucleotide disclosed herein depending upon the intended use (e.g.,an EPSP synthase polynucleotide comprising SEQ ID NO:1). By “contiguous”nucleotides is intended nucleotide residues that are immediatelyadjacent to one another.

Fragments of the polynucleotides of the present invention generally willencode polypeptide fragments that retain the biological activity of thefull-length glyphosate resistance protein; i.e., herbicide-resistanceactivity. By “retains herbicide resistance activity” is intended thatthe fragment will have at least about 30%, at least about 50%, at leastabout 70%, at least about 80%, 85%, 90%, 95%, 100%, 110%, 125%, 150%,175%, 200%, 250%, at least about 300% or greater of the herbicideresistance activity of the full-length glypho sate resistance proteindisclosed herein as SEQ ID NO:2, 3, or 5. Methods for measuringherbicide resistance activity are well known in the art. See, forexample, U.S. Pat. Nos. 4,535,060, and 5,188,642, each of which areherein incorporated by reference in their entirety.

A fragment of a polynucleotide that encodes a biologically activeportion of a polypeptide of the invention will encode at least about 15,25, 30, 50, 75, 100, 125, 150, 175, 200, 250, 300, 350, 400 contiguousamino acids, or up to the total number of amino acids present in afull-length polypeptide of the invention.

The invention also encompasses variant polynucleotides. “Variants” ofthe polynucleotide include those sequences that encode the polypeptidesdisclosed herein but that differ conservatively because of thedegeneracy of the genetic code, as well as those that are sufficientlyidentical.

The term “sufficiently identical” is intended a polypeptide orpolynucleotide sequence that has at least about 60% or 65% sequenceidentity, about 70% or 75% sequence identity, about 80% or 85% sequenceidentity, about 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99%sequence identity compared to a reference sequence using one of thealignment programs using standard parameters. One of skill in the artwill recognize that these values can be appropriately adjusted todetermine corresponding identity of polypeptides encoded by twopolynucleotides by taking into account codon degeneracy, amino acidsimilarity, reading frame positioning, and the like.

Bacterial genes quite often possess multiple methionine initiationcodons in proximity to the start of the open reading frame. Often,translation initiation at one or more of these start codons will lead togeneration of a functional protein. These start codons can include ATGcodons. However, bacteria such as Bacillus sp. also recognize the codonGTG as a start codon, and proteins that initiate translation at GTGcodons contain a methionine at the first amino acid. Furthermore, it isnot often determined a priori which of these codons are used naturallyin the bacterium. Thus, it is understood that use of one of thealternate methionine codons may lead to generation of variants thatconfer herbicide resistance. These herbicide resistance proteins areencompassed in the present invention and may be used in the methods ofthe present invention.

Naturally occurring allelic variants can be identified with the use ofwell-known molecular biology techniques, such as polymerase chainreaction (PCR) and hybridization techniques as outlined below. Variantpolynucleotides also include synthetically derived polynucleotides thathave been generated, for example, by using site-directed or othermutagenesis strategies but which still encode the polypeptide having thedesired biological activity.

The skilled artisan will further appreciate that changes can beintroduced by further mutation of the polynucleotides of the inventionthereby leading to further changes in the amino acid sequence of theencoded polypeptides, without altering the biological activity of thepolypeptides. Thus, variant isolated polynucleotides can be created byintroducing one or more additional nucleotide substitutions, additions,or deletions into the corresponding polynucleotide encoding the EPSPsynthase domain disclosed herein, such that one or more amino acidsubstitutions, additions or deletions are introduced into the encodedpolypeptide. Further mutations can be introduced by standard techniques,such as site-directed mutagenesis and PCR-mediated mutagenesis, or geneshuffling techniques. Such variant polynucleotides are also encompassedby the present invention.

Variant polynucleotides can be made by introducing mutations randomlyalong all or part of the coding sequence, such as by saturationmutagenesis, and the resultant mutants can be screened for the abilityto confer herbicide resistance activity to identify mutants that retainactivity.

Gene shuffling or sexual PCR procedures (for example, Smith (1994)Nature 370:324-325; U.S. Pat. Nos. 5,837,458; 5,830,721; 5,811,238; and5,733,731, each of which is herein incorporated by reference) can beused to further modify or enhance polynucleotides and polypeptideshaving the EPSP synthase domain of the present invention (for example,polypeptides that confer glyphosate resistance). Gene shuffling involvesrandom fragmentation of several mutant DNAs followed by their reassemblyby PCR into full length molecules. Examples of various gene shufflingprocedures include, but are not limited to, assembly following DNasetreatment, the staggered extension process (STEP), and random priming invitro recombination. In the DNase mediated method, DNA segments isolatedfrom a pool of positive mutants are cleaved into random fragments withDNaseI and subjected to multiple rounds of PCR with no added primer. Thelengths of random fragments approach that of the uncleaved segment asthe PCR cycles proceed, resulting in mutations in different clonesbecoming mixed and accumulating in some of the resulting sequences.Multiple cycles of selection and shuffling have led to the functionalenhancement of several enzymes (Stemmer (1994) Nature 370:389-391;Stemmer (1994) Proc. Natl. Acad. Sci. USA 91:10747-10751; Crameri et al.(1996) Nat. Biotechnol. 14:315-319; Zhang et al. (1997) Proc. Natl.Acad. Sci. USA 94:4504-4509; and Crameri et al. (1997) Nat. Biotechnol.15:436-438). Such procedures could be performed, for example, onpolynucleotides encoding polypeptides having the sequence domain of thepresent invention to generate polypeptides that confer glyphosateresistance.

Using methods such as PCR, hybridization, and the like correspondingherbicide resistance sequences can be identified by looking for EPSPsynthase domains of the present invention. See, for example, Sambrookand Russell (2001) Molecular Cloning: A Laboratory Manual (Cold SpringHarbor Laboratory Press, Cold Spring Harbor, N.Y.) and Innis et al.(1990) PCR Protocols: A Guide to Methods and Applications (AcademicPress, NY).

B. Isolated Proteins and Variants and Fragments Thereof

Herbicide resistance polypeptides are also encompassed within thepresent invention. An herbicide resistance polypeptide that issubstantially free of cellular material includes preparations ofpolypeptides having less than about 30%, 20%, 10%, or 5% (by dry weight)of non-herbicide resistance polypeptide (also referred to herein as a“contaminating protein”). In the present invention, “herbicideresistance protein” is intended an EPSP synthase polypeptide having thesequence domain of the invention. Fragments, biologically activeportions, and variants thereof are also provided, and may be used topractice the methods of the present invention.

“Fragments” or “biologically active portions” include polypeptidefragments comprising a portion of an amino acid sequence encoding anherbicide resistance protein and that retains herbicide resistanceactivity. A biologically active portion of an herbicide resistanceprotein can be a polypeptide that is, for example, 10, 25, 50, 100 ormore amino acids in length. Such biologically active portions can beprepared by recombinant techniques and evaluated for herbicideresistance activity.

By “variants” is intended proteins or polypeptides having an amino acidsequence that is at least about 60%, 65%, about 70%, 75%, about 80%,85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identical to anEPSP synthase polypeptide having the EPSP synthase domain of the presentinvention. One of skill in the art will recognize that these values canbe appropriately adjusted to determine corresponding identity ofpolypeptides encoded by two polynucleotides by taking into account codondegeneracy, amino acid similarity, reading frame positioning, and thelike.

For example, conservative amino acid substitutions may be made at one ormore nonessential amino acid residues. A “nonessential” amino acidresidue is a residue that can be altered from the wild-type sequence ofa polypeptide without altering the biological activity, whereas an“essential” amino acid residue is required for biological activity. A“conservative amino acid substitution” is one in which the amino acidresidue is replaced with an amino acid residue having a similar sidechain. Families of amino acid residues having similar side chains havebeen defined in the art. These families include amino acids with basicside chains (e.g., lysine, arginine, histidine), acidic side chains(e.g., aspartic acid, glutamic acid), uncharged polar side chains (e.g.,glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine),nonpolar side chains (e.g., alanine, valine, leucine, isoleucine,proline, phenylalanine, methionine, tryptophan), beta-branched sidechains (e.g., threonine, valine, isoleucine) and aromatic side chains(e.g., tyrosine, phenylalanine, tryptophan, histidine). Amino acidsubstitutions may be made in nonconserved regions that retain function.In general, such substitutions would not be made for conserved aminoacid residues, or for amino acid residues residing within a conservedmotif, where such residues are essential for polypeptide activity.However, one of skill in the art would understand that functionalvariants may have minor conserved or nonconserved alterations in theconserved residues.

Antibodies to the polypeptides of the present invention, or to variantsor fragments thereof, are also encompassed. Methods for producingantibodies are well known in the art (see, for example, Harlow and Lane(1988) Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory,Cold Spring Harbor, N.Y.; U.S. Pat. No. 4,196,265).

C. Polynucleotide Constructs

The polynucleotides encoding the EPSP synthase polypeptides of thepresent invention may be modified to obtain or enhance expression inplant cells. The polynucleotides encoding the polypeptides identifiedherein may be provided in expression cassettes for expression in theplant of interest. A “plant expression cassette” includes a DNAconstruct, including a recombinant DNA construct, that is capable ofresulting in the expression of a polynucleotide in a plant cell. Thecassette can include in the 5′-3′ direction of transcription, atranscriptional initiation region (i.e., promoter, particularly aheterologous promoter) operably-linked to one or more polynucleotides ofinterest, and/or a translation and transcriptional termination region(i.e., termination region) functional in plants. The cassette mayadditionally contain at least one additional polynucleotide to beintroduced into the organism, such as a selectable marker gene.Alternatively, the additional polynucleotide(s) can be provided onmultiple expression cassettes. Such an expression cassette is providedwith a plurality of restriction sites for insertion of thepolynucleotide(s) to be under the transcriptional regulation of theregulatory regions.

“Heterologous” generally refers to the polynucleotide or polypeptidethat is not endogenous to the cell or is not endogenous to the locationin the native genome in which it is present, and has been added to thecell by infection, transfection, microinjection, electroporation,microprojection, or the like. By “operably linked” is intended afunctional linkage between two polynucleotides. For example, when apromoter is operably linked to a DNA sequence, the promoter sequenceinitiates and mediates transcription of the DNA sequence. It isrecognized that operably linked polynucleotides may or may not becontiguous and, where used to reference the joining of two polypeptidecoding regions, the polypeptides are expressed in the same readingframe.

The promoter may be any polynucleotide sequence which showstranscriptional activity in the chosen plant cells, plant parts, orplants. The promoter may be native or analogous, or foreign orheterologous, to the plant host and/or to the DNA sequence of theinvention. Where the promoter is “native” or “analogous” to the planthost, it is intended that the promoter is found in the native plant intowhich the promoter is introduced. Where the promoter is “foreign” or“heterologous” to the DNA sequence of the invention, it is intended thatthe promoter is not the native or naturally occurring promoter for theoperably linked DNA sequence of the invention. The promoter may beinducible or constitutive. It may be naturally-occurring, may becomposed of portions of various naturally-occurring promoters, or may bepartially or totally synthetic. Guidance for the design of promoters isprovided by studies of promoter structure, such as that of Harley andReynolds (1987) Nucleic Acids Res. 15:2343-2361. Also, the location ofthe promoter relative to the transcription start may be optimized. See,e.g., Roberts et al. (1979) Proc. Natl. Acad. Sci. USA, 76:760-764. Manysuitable promoters for use in plants are well known in the art.

For instance, suitable constitutive promoters for use in plants include:the promoters from plant viruses, such as the peanut chlorotic streakcaulimovirus (PClSV) promoter (U.S. Pat. No. 5,850,019); the 35Spromoter from cauliflower mosaic virus (CaMV) (Odell et al. (1985)Nature 313:810-812); promoters of Chlorella virus methyltransferasegenes (U.S. Pat. No. 5,563,328) and the full-length transcript promoterfrom figwort mosaic virus (FMV) (U.S. Pat. No. 5,378,619); the promotersfrom such genes as rice actin (McElroy et al. (1990) Plant Cell2:163-171); ubiquitin (Christensen et al. (1989) Plant Mol. Biol.12:619-632 and Christensen et al. (1992) Plant Mol. Biol. 18:675-689);pEMU (Last et al. (1991) Theor. Appl. Genet. 81:581-588); MAS (Velten etal. (1984) EMBO J. 3:2723-2730); maize H3 histone (Lepetit et al. (1992)Mol. Gen. Genet. 231:276-285 and Atanassova et al. (1992) Plant J.2(3):291-300); Brassica napus ALS3 (PCT application WO 97/41228); andpromoters of various Agrobacterium genes (see U.S. Pat. Nos. 4,771,002;5,102,796; 5,182,200; and 5,428,147).

Suitable inducible promoters for use in plants include: the promoterfrom the ACE1 system which responds to copper (Mett et al. (1993) PNAS90:4567-4571); the promoter of the maize In2 gene which responds tobenzenesulfonamide herbicide safeners (Hershey et al. (1991) Mol. Gen.Genetics 227:229-237 and Gatz et al. (1994) Mol. Gen. Genetics243:32-38); and the promoter of the Tet repressor from Tn10 (Gatz et al.(1991) Mol. Gen. Genet. 227:229-237). Another inducible promoter for usein plants is one that responds to an inducing agent to which plants donot normally respond. An exemplary inducible promoter of this type isthe inducible promoter from a steroid hormone gene, the transcriptionalactivity of which is induced by a glucocorticosteroid hormone (Schena etal. (1991) Proc. Natl. Acad. Sci. USA 88:10421) or the recentapplication of a chimeric transcription activator, XVE, for use in anestrogen receptor-based inducible plant expression system activated byestradiol (Zuo et al. (2000) Plant J., 24:265-273). Other induciblepromoters for use in plants are described in EP 332104, PCT WO 93/21334and PCT WO 97/06269 which are herein incorporated by reference in theirentirety. Promoters composed of portions of other promoters andpartially or totally synthetic promoters can also be used. See, e.g., Niet al. (1995) Plant J. 7:661-676 and PCT WO 95/14098 describing suchpromoters for use in plants.

The promoter may include, or be modified to include, one or moreenhancer elements. In some embodiments, the promoter may include aplurality of enhancer elements. Promoters containing enhancer elementsprovide for higher levels of transcription as compared to promoters thatdo not include them. Suitable enhancer elements for use in plantsinclude the PClSV enhancer element (U.S. Pat. No. 5,850,019), the CaMV35S enhancer element (U.S. Pat. Nos. 5,106,739 and 5,164,316) and theFMV enhancer element (Maiti et al. (1997) Transgenic Res. 6:143-156).See also PCT WO 96/23898.

Often, such constructs can contain 5′ and 3′ untranslated regions. Suchconstructs may contain a “signal sequence” or “leader sequence” tofacilitate co-translational or post-translational transport of thepeptide of interest to certain intracellular structures such as thechloroplast (or other plastid), endoplasmic reticulum, or Golgiapparatus, or to be secreted. For example, the construct can beengineered to contain a signal peptide to facilitate transfer of thepeptide to the endoplasmic reticulum. By “signal sequence” is intended asequence that is known or suspected to result in cotranslational orpost-translational peptide transport across the cell membrane. Ineukaryotes, this typically involves secretion into the Golgi apparatus,with some resulting glycosylation. By “leader sequence” is intended anysequence that, when translated, results in an amino acid sequencesufficient to trigger co-translational transport of the peptide chain toa sub-cellular organelle. Thus, this includes leader sequences targetingtransport and/or glycosylation by passage into the endoplasmicreticulum, passage to vacuoles, plastids including chloroplasts,mitochondria, and the like. It may also be preferable to engineer theplant expression cassette to contain an intron, such that mRNAprocessing of the intron is required for expression.

By “3′ untranslated region” is intended a polynucleotide locateddownstream of a coding sequence. Polyadenylation signal sequences andother sequences encoding regulatory signals capable of affecting theaddition of polyadenylic acid tracts to the 3′ end of the mRNA precursorare 3′ untranslated regions. By “5′ untranslated region” is intended apolynucleotide located upstream of a coding sequence.

Other upstream or downstream untranslated elements include enhancers.Enhancers are polynucleotides that act to increase the expression of apromoter region. Enhancers are well known in the art and include, butare not limited to, the SV40 enhancer region and the 35S enhancerelement.

The termination region may be native with the transcriptional initiationregion, may be native with the sequence of the present invention, or maybe derived from another source. Convenient termination regions areavailable from the Ti-plasmid of A. tumefaciens, such as the octopinesynthase and nopaline synthase termination regions. See also Guerineauet al. (1991) Mol. Gen. Genet. 262:141-144; Proudfoot (1991) Cell64:671-674; Sanfacon et al. (1991) Genes Dev. 5:141-149; Mogen et al.(1990) Plant Cell 2:1261-1272; Munroe et al. (1990) Gene 91:151-158;Ballas et al. (1989) Nucleic Acids Res. 17:7891-7903; and Joshi et al.(1987) Nucleic Acid Res. 15:9627-9639.

In one aspect of the invention, synthetic DNA sequences are designed fora given polypeptide, such as the polypeptides of the invention.Expression of the open reading frame of the synthetic DNA sequence in acell results in production of the polypeptide of the invention.Synthetic DNA sequences can be useful to simply remove unwantedrestriction endonuclease sites, to facilitate DNA cloning strategies, toalter or remove any potential codon bias, to alter or improve GCcontent, to remove or alter alternate reading frames, and/or to alter orremove intron/exon splice recognition sites, polyadenylation sites,Shine-Delgarno sequences, unwanted promoter elements and the like thatmay be present in a native DNA sequence. It is also possible thatsynthetic DNA sequences may be utilized to introduce other improvementsto a DNA sequence, such as introduction of an intron sequence, creationof a DNA sequence that in expressed as a protein fusion to organelletargeting sequences, such as chloroplast transit peptides,apoplast/vacuolar targeting peptides, or peptide sequences that resultin retention of the resulting peptide in the endoplasmic reticulum.Synthetic genes can also be synthesized using host cell-preferred codonsfor improved expression, or may be synthesized using codons at ahost-preferred codon usage frequency. See, for example, Campbell andGowri (1990) Plant Physiol. 92:1-11; U.S. Pat. Nos. 6,320,100;6,075,185; 5,380,831; and 5,436,391, U.S. Published Application Nos.20040005600 and 20010003849, and Murray et al. (1989) Nucleic Acids Res.17:477-498, herein incorporated by reference.

In one embodiment, the polynucleotides of interest are targeted to thechloroplast for expression. In this manner, where the polynucleotide ofinterest is not directly inserted into the chloroplast, the expressioncassette will additionally contain a polynucleotide encoding a transitpeptide to direct the nucleotide of interest to the chloroplasts. Suchtransit peptides are known in the art. See, for example, Von Heijne etal. (1991) Plant Mol. Biol. Rep. 9:104-126; Clark et al. (1989) J. Biol.Chem. 264:17544-17550; Della-Cioppa et al. (1987) Plant Physiol.84:965-968; Romer et al. (1993) Biochem. Biophys. Res. Commun.196:1414-1421; and Shah et al. (1986) Science 233:478-481.

The polynucleotides of interest to be targeted to the chloroplast may beoptimized for expression in the chloroplast to account for differencesin codon usage between the plant nucleus and this organelle. In thismanner, the polynucleotides of interest may be synthesized usingchloroplast-preferred codons. See, for example, U.S. Pat. No. 5,380,831,herein incorporated by reference.

This plant expression cassette can be inserted into a planttransformation vector. By “transformation vector” is intended a DNAmolecule that allows for the transformation of a cell. Such a moleculemay consist of one or more expression cassettes, and may be organizedinto more than one vector DNA molecule. For example, binary vectors areplant transformation vectors that utilize two non-contiguous DNA vectorsto encode all requisite cis- and trans-acting functions fortransformation of plant cells (Hellens and Mullineaux (2000) Trends inPlant Science 5:446-451). “Vector” refers to a polynucleotide constructdesigned for transfer between different host cells. “Expression vector”refers to a vector that has the ability to incorporate, integrate andexpress heterologous DNA sequences or fragments in a foreign cell.

The plant transformation vector comprises one or more DNA vectors forachieving plant transformation. For example, it is a common practice inthe art to utilize plant transformation vectors that comprise more thanone contiguous DNA segment. These vectors are often referred to in theart as binary vectors. Binary vectors as well as vectors with helperplasmids are most often used for Agrobacterium-mediated transformation,where the size and complexity of DNA segments needed to achieveefficient transformation is quite large, and it is advantageous toseparate functions onto separate DNA molecules. Binary vectors typicallycontain a plasmid vector that contains the cis-acting sequences requiredfor T-DNA transfer (such as left border and right border), a selectablemarker that is engineered to be capable of expression in a plant cell,and a “polynucleotide of interest” (a polynucleotide engineered to becapable of expression in a plant cell for which generation of transgenicplants is desired). Also present on this plasmid vector are sequencesrequired for bacterial replication. The cis-acting sequences arearranged in a fashion to allow efficient transfer into plant cells andexpression therein. For example, the selectable marker sequence and thesequence of interest are located between the left and right borders.Often a second plasmid vector contains the trans-acting factors thatmediate T-DNA transfer from Agrobacterium to plant cells. This plasmidoften contains the virulence functions (Vir genes) that allow infectionof plant cells by Agrobacterium, and transfer of DNA by cleavage atborder sequences and vir-mediated DNA transfer, as is understood in theart (Hellens and Mullineaux (2000) Trends in Plant Science, 5:446-451).Several types of Agrobacterium strains (e.g., LB A4404, GV3101, EHA101,EHA105, etc.) can be used for plant transformation. The second plasmidvector is not necessary for introduction of polynucleotides into plantsby other methods such as microprojection, microinjection,electroporation, polyethylene glycol, etc.

D. Plant Transformation

Methods of the invention involve introducing a nucleotide construct intoa plant. By “introducing” is intended to present to the plant thenucleotide construct in such a manner that the construct gains access tothe interior of a cell of the plant. The methods of the invention do notrequire that a particular method for introducing a nucleotide constructto a plant is used, only that the nucleotide construct gains access tothe interior of at least one cell of the plant. Methods for introducingnucleotide constructs into plants are known in the art including, butnot limited to, stable transformation methods, transient transformationmethods, and virus-mediated methods.

In general, plant transformation methods involve transferringheterologous DNA into target plant cells (e.g. immature or matureembryos, suspension cultures, undifferentiated callus, protoplasts,etc.), followed by applying a maximum threshold level of appropriateselection (depending on the selectable marker gene and in this case“glyphosate”) to recover the transformed plant cells from a group ofuntransformed cell mass. Explants are typically transferred to a freshsupply of the same medium and cultured routinely. Subsequently, thetransformed cells are differentiated into shoots after placing onregeneration medium supplemented with a maximum threshold level ofselecting agent (e.g. “glyphosate”). The shoots are then transferred toa selective rooting medium for recovering rooted shoot or plantlet. Thetransgenic plantlet then grow into mature plants and produce fertileseeds (e.g. Hiei et al. (1994) The Plant Journal 6:271-282; Ishida etal. (1996) Nature Biotechnology 14:745-750). Explants are typicallytransferred to a fresh supply of the same medium and cultured routinely.A general description of the techniques and methods for generatingtransgenic plants are found in Ayres and Park (1994) Critical Reviews inPlant Science 13:219-239 and Bommineni and Jauhar (1997) Maydica42:107-120. Since the transformed material contains many cells; bothtransformed and non-transformed cells are present in any piece ofsubjected target callus or tissue or group of cells. The ability to killnon-transformed cells and allow transformed cells to proliferate resultsin transformed plant cultures. Often, the ability to removenon-transformed cells is a limitation to rapid recovery of transformedplant cells and successful generation of transgenic plants. Molecularand biochemical methods can be used to confirm the presence of theintegrated heterologous gene of interest in the genome of transgenicplant.

Generation of transgenic plants may be performed by one of severalmethods, including, but not limited to, introduction of heterologous DNAby Agrobacterium into plant cells (Agrobacterium-mediatedtransformation), bombardment of plant cells with heterologous foreignDNA adhered to particles, and various other non-particle direct-mediatedmethods (e.g. Hiei et al. (1994) The Plant Journal 6:271-282; Ishida etal. (1996) Nature Biotechnology 14:745-750; Ayres and Park (1994)Critical Reviews in Plant Science 13:219-239; Bommineni and Jauhar(1997) Maydica 42:107-120) to transfer DNA.

Methods for transformation of chloroplasts are known in the art. See,for example, Svab et al. (1990) Proc. Natl. Acad. Sci. USA 87:8526-8530;Svab and Maliga (1993) Proc. Natl. Acad. Sci. USA 90:913-917; Svab andMaliga (1993) EMBO J. 12:601-606. The method relies on particle gundelivery of DNA containing a selectable marker and targeting of the DNAto the plastid genome through homologous recombination. Additionally,plastid transformation can be accomplished by transactivation of asilent plastid-borne transgene by tissue-preferred expression of anuclear-encoded and plastid-directed RNA polymerase. Such a system hasbeen reported in McBride et al. (1994) Proc. Natl. Acad. Sci. USA91:7301-7305.

The cells that have been transformed may be grown into plants inaccordance with conventional ways. See, for example, McCormick et al.(1986) Plant Cell Reports 5:81-84. These plants may then be grown, andeither pollinated with the same transformed strain or different strains,and the resulting hybrid having constitutive expression of the desiredphenotypic characteristic identified. Two or more generations may begrown to ensure that expression of the desired phenotypic characteristicis stably maintained and inherited and then seeds harvested to ensureexpression of the desired phenotypic characteristic has been achieved.In this manner, the present invention provides transformed seed (alsoreferred to as “transgenic seed”) having a nucleotide construct of theinvention, for example, an expression cassette of the invention, stablyincorporated into their genome.

E. Evaluation of Plant Transformation

Following introduction of heterologous foreign DNA into plant cells, thetransformation or integration of the heterologous gene in the plantgenome is confirmed by various methods such as analysis of nucleicacids, proteins and metabolites associated with the integrated gene.

PCR analysis is a rapid method to screen transformed cells, tissue orshoots for the presence of incorporated gene at the earlier stage beforetransplanting into the soil (Sambrook and Russell (2001) MolecularCloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, ColdSpring Harbor, N.Y.)). PCR is carried out using oligonucleotide primersspecific to the gene of interest or Agrobacterium vector background,etc.

Plant transformation may be confirmed by Southern blot analysis ofgenomic DNA (Sambrook and Russell (2001) supra). In general, total DNAis extracted from the transformant, digested with appropriaterestriction enzymes, fractionated in an agarose gel and transferred to anitrocellulose or nylon membrane. The membrane or “blot” can then beprobed with, for example, radiolabeled ³²P target DNA fragment toconfirm the integration of the introduced gene in the plant genomeaccording to standard techniques (Sambrook and Russell, 2001, supra).

In Northern analysis, RNA is isolated from specific tissues oftransformant, fractionated in a formaldehyde agarose gel, and blottedonto a nylon filter according to standard procedures that are routinelyused in the art (Sambrook and Russell (2001) supra). Expression of RNAencoded by grg sequences of the invention is then tested by hybridizingthe filter to a radioactive probe derived from a GDC by methods known inthe art (Sambrook and Russell (2001) supra)

Western blot and biochemical assays and the like may be carried out onthe transgenic plants to determine the presence of protein encoded bythe herbicide resistance gene by standard procedures (Sambrook andRussell (2001) supra) using antibodies that bind to one or more epitopespresent on the herbicide resistance protein.

In one aspect of the invention, the grg genes described herein areuseful as markers to assess transformation of bacterial or plant cells.

F. Plants and Plant Parts

By “plant” is intended whole plants, plant organs (e.g., leaves, stems,roots, etc.), seeds, plant cells, propagules, embryos and progeny of thesame. Plant cells can be differentiated or undifferentiated (e.g.,callus, suspension culture cells, protoplasts, leaf cells, root cells,phloem cells, pollen). The present invention may be used forintroduction of polynucleotides into any plant species, including, butnot limited to, monocots and dicots. Examples of plants of interestinclude, but are not limited to, corn (maize), sorghum, wheat,sunflower, tomato, crucifers, peppers, potato, cotton, rice, soybean,sugarbeet, sugarcane, tobacco, barley, and oilseed rape, Brassica sp.,alfalfa, rye, millet, safflower, peanuts, sweet potato, cassava, coffee,coconut, pineapple, citrus trees, cocoa, tea, banana, avocado, fig,guava, mango, olive, papaya, cashew, macadamia, almond, oats,vegetables, ornamentals, and conifers.

Vegetables include, but are not limited to, tomatoes, lettuce, greenbeans, lima beans, peas, and members of the genus Curcumis such ascucumber, cantaloupe, and musk melon. Ornamentals include, but are notlimited to, azalea, hydrangea, hibiscus, roses, tulips, daffodils,petunias, carnation, poinsettia, and chrysanthemum. Crop plants are alsoof interest, including, for example, maize, sorghum, wheat, sunflower,tomato, crucifers, peppers, potato, cotton, rice, soybean, sugarbeet,sugarcane, tobacco, barley, oilseed rape, etc.

This invention is suitable for any member of the monocot plant familyincluding, but not limited to, maize, rice, barley, oats, wheat,sorghum, rye, sugarcane, pineapple, yams, onion, banana, coconut, anddates.

G. Methods for Increasing Plant Yield

Methods for increasing plant yield are provided. The methods compriseintroducing into a plant or plant cell a polynucleotide comprising a grgsequence disclosed herein. As defined herein, the “yield” of the plantrefers to the quality and/or quantity of biomass produced by the plant.By “biomass” is intended any measured plant product. An increase inbiomass production is any improvement in the yield of the measured plantproduct. Increasing plant yield has several commercial applications. Forexample, increasing plant leaf biomass may increase the yield of leafyvegetables for human or animal consumption. Additionally, increasingleaf biomass can be used to increase production of plant-derivedpharmaceutical or industrial products. An increase in yield can compriseany statistically significant increase including, but not limited to, atleast a 1% increase, at least a 3% increase, at least a 5% increase, atleast a 10% increase, at least a 20% increase, at least a 30%, at leasta 50%, at least a 70%, at least a 100% or a greater increase.

In specific methods, the plant is treated with an effectiveconcentration of an herbicide, where the herbicide application resultsin enhanced plant yield. By “effective concentration” is intended theconcentration which allows the increased yield in the plant. Sucheffective concentrations for herbicides of interest are generally knownin the art. The herbicide may be applied either pre- or post emergencein accordance with usual techniques for herbicide application to fieldscomprising crops which have been rendered resistant to the herbicide byheterologous expression of a grg gene of the invention.

Methods for conferring herbicide resistance in a plant or plant part arealso provided. In such methods, a grg polynucleotide disclosed herein isintroduced into the plant, wherein expression of the polynucleotideresults in glyphosate tolerance or resistance. Plants produced via thismethod can be treated with an effective concentration of an herbicideand display an increased tolerance to the herbicide. An “effectiveconcentration” of an herbicide in this application is an amountsufficient to slow or stop the growth of plants or plant parts that arenot naturally resistant or rendered resistant to the herbicide.

H. Methods of Controlling Weeds in a Field

Methods for selectively controlling weeds in a field containing a plantare also provided. In one embodiment, the plant seeds or plants areglyphosate resistant as a result of a grg polynucleotide disclosedherein being inserted into the plant seed or plant. In specific methods,the plant is treated with an effective concentration of an herbicide,where the herbicide application results in a selective control of weedsor other untransformed plants. By “effective concentration” is intendedthe concentration which controls the growth or spread of weeds or otheruntransformed plants without significantly affecting theglyphosate-resistant plant or plant seed. Such effective concentrationsfor herbicides of interest are generally known in the art. The herbicidemay be applied either pre- or post emergence in accordance with usualtechniques for herbicide application to fields comprising plants orplant seeds which have been rendered resistant to the herbicide.

I. Temperature Spectrum

Several studies of glyphosate metabolism in plants have been carriedout, and reveal that glyphosate is not metabolized by plants or ismetabolized very slowly. Glyphosate penetrates the cuticle rapidly, andis translocated throughout plants over a considerable period of time(reviewed in Kearney and Kaufman, Eds (1988) Herbicides; Chemistry,Degradation & Mode of Action Marcel Dekker, Inc., New York, 3:1-70 andGrossbard and Atkinson, Eds. (1985) The Herbicide GlyphosateButterworths, London, p. 25-34). Thus, it is likely that glyphosatetolerance is necessary over a sustained period of time followingglyphosate exposure in agronomically-important plants. Wheretemperatures frequently exceed 30° C. during the growing season, itwould be advantageous to employ a glyphosate-tolerance EPSP synthasethat maintains activity at elevated temperatures.

In one embodiment of the present invention, the EPSP synthase exhibitsthermal stability at a temperature that is higher or lower than ambientenvironmental temperature. By “thermal stability” is intended that theenzyme is active at a higher or lower temperature than ambientenvironmental temperature for a longer period of time than an EPSPsynthase that is not thermal stable at that temperature. For example, athermal stable EPSP synthase has enzymatic activity for greater thanabout 1 hour, greater than about 2 hours, about 3, about 4, about 5,about 6, about 7, about 8, about 9, about 10, about 11, about 12, about13, about 14, about 15, about 20, about 25 hours, or longer, at atemperature that is higher or lower than ambient environmentaltemperature. For the purposes of the present invention, “ambient”environmental temperature is about 30° C. In some embodiments, a higherthan ambient temperature is a temperature at or above about 32° C.,about 34° C., about 37° C., about 40° C., about 45° C., about 50° C.,about 55° C., about 60° C., about 65° C., or higher. A lower thanambient temperature is a temperature at or below about 28° C., belowabout 27° C., about 26° C., about 25° C., about 23° C., about 20° C.,about 18° C., about 15° C., about 10° C., at or below about 5° C., oraround 0° C. Methods to assay for EPSP synthase activity are discussedin further details elsewhere herein. For the purposes of the presentinvention, a thermal stable EPSP synthase is considered active when itfunctions at about 90% to 100%, about 80% to about 90%, about 70% toabout 80%, about 60% to about 70% or about 50% to about 60% of themaximum activity level observed at the optimum temperature for thatenzyme.

Thus, provided herein are methods and compositions for increasingglyphosate tolerance at temperatures higher than ambient environmentaltemperatures. In one embodiment, the methods comprise introducing into aplant a nucleotide sequence encoding the glyphosate tolerance EPSPsynthase enzyme set forth in SEQ ID NO:8, 10, 14, 28, 30, 32, or 34, andgrowing the plant at a temperature that is higher than ambientenvironmental temperature. In specific embodiments, the growingtemperature is higher than ambient temperature for an average of atleast about 2 hours per day, at least about 3 hours per day, at leastabout 4 hours per day, at least about 5, about 6, about 7, about 8,about 9, about 10, about 11, about 12, about 14, about 16, about 18,about 20, at least about 22 hours per day, or up to about 24 hours a dayduring the growing season of the plant.

In another embodiment, the method comprises introducing into a plant anucleotide sequence encoding the glyphosate tolerant EPSP synthaseenzyme set forth in SEQ ID NO:8, 10, 14, 28, 30, 32, or 34, contactingthe plant with an herbicidally-effective concentration of glyphosate,and growing the plant at a temperature that exceeds ambientenvironmental temperature for at least 1 hour, at least about 2 hours,at least about 3, at least about 4, or more hours per day for at least2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ormore days after glyphosate is applied to the plant, wherein the days inwhich the temperature exceeds ambient environmental temperature occurduring the growing season of the plant.

The following examples are offered by way of illustration and not by wayof limitation.

EXPERIMENTAL Example 1 syngrg23 Design and Expression

GRG23 (SEQ ID NO:2) is an EPSP synthase that possesses excellent kineticvalues for Km, Ki and Vmax (U.S. Pat. No. 7,674,958). A novel genesequence encoding the GRG23 protein (U.S. Pat. No. 7,674,958) wasdesigned and synthesized. The resulting sequence is provided herein asSEQ ID NO:6, and is herein designated “syngrg23.” The open reading framewas cloned into the expression vector pRSF1b (Invitrogen) by methodsknown in the art.

The syngrg23 gene encoding GRG23 was cloned into a pUC19 vector tocreate pAX748. PCR primers that flanked syngrg23 in this vector wereused to amplify syngrg23 from pAX748 using the Mutazyme II system(Stratagene) to introduce random mutations into the syngrg23 codingregion. The template was diluted 1:50 in the error-prone PCR reaction,and amplification was carried out for 30 cycles. The resulting PCRproduct was digested with the restriction enzymes BamH I and Sgs I,gel-purified, and ligated into the vector pRSF1b to create a mutagenizedsyngrg23 library.

The mutagenized syngrg23 libraries were transformed into E. coli strainBL21*DE3 star (Invitrogen). Following transformation, individualcolonies were plated on 1×M63 medium containing 150 mM glyphosate toselect for clones that had retained enzymatic activity and growthtolerance.

Example 2 Screening for Glyphosate Resistance on Plates

Library ligations were transformed into BL21*DE3 competent E. coli cells(Invitrogen). The transformations were performed according to themanufacturer's instructions with the following modifications. Afterincubation for 1 hour at 37° C. in SOC medium, the cells were sedimentedby centrifugation (5 minutes, 1000×g, 4° C.). The cells were washed with1 ml M63+, centrifuged again, and the supernatant decanted. The cellswere washed a second time with 1 ml M63+ and resuspended in 200 ul M63+.

For selection of mutant GRG23 enzymes conferring glyphosate resistancein E. coli, the cells were plated onto M63+ agar medium platescontaining 150 mM glyphosate, 0.05 mM IPTG(isopropyl-beta-D-thiogalactopyranoside), and 50 μg/ml kanamycin. M63+medium contains 100 mM KH₂PO₄, 15 mM (NH₄)₂SO₄, 50 μM CaCl₂, 1 μM FeSO₄,50 μM MgCl₂, 55 mM glucose, 25 mg/liter L-proline, 10 mg/liter thiamineHCl, sufficient NaOH to adjust the pH to 7.0, and 15 g/liter agar. Theplates were incubated for 36 hours at 37° C.

Individual colonies were picked and arrayed into 384-well plates. Two384-well plates were created in this manner. A third plate of 384 cloneswas picked from colonies that grown on plates lacking glyphosate.

Example 3 Isolation and Analysis of Glyphosate Resistant GRG23 Variants

BL21*DE3 cells transformed with mutagenized syngrg23 and/or grg23variants were identified by growth on glyphosate plates. Extracts ofmutagenized syngrg23 and grgr23 variants were prepared and assayed forimproved enzymatic activity. Colonies identified on glyphosate plateswere pinned into 96-well blocks containing LB medium and were grown toan O.D. of about 0.6. IPTG was then added (0.5 mM) and the blocks wereincubated overnight at 20° C. to induce protein expression. Proteinextracts were prepared from the cell pellets using POP culture reagent(Novagen) and Lysonase (Novagen), and the enzymatic activity in thecrude lysates was measured after heating the extracts for 30 min at 37°C. Extracts with activity greater than two standard deviations above themean of a set of extracts containing the appropriate control protein(for example GRG23) were selected for further analysis.

Clones showing increased activity after incubation as crude extractswere grown in 250 mL LB cultures, and protein expression induced withIPTG. Following induction, the mutant GRG23 protein was purified fromeach culture by affinity chromatography using a cobalt resin (Novagen).The purified proteins were then tested for enzymatic activity followingheating for 0, 2, 4, and approximately 16 hours at 37° C.

Example 4 Improved GRG23 Variants

From a DNA library of mutagenized syngrg23, several clones with improvedactivity at 37° C. were identified. The DNA sequences of the clonescorresponding to these extracts was determined. Table 1 shows the aminoacid changes identified in six variants of GRG23 that retainedglyphosate resistance: grg23(L3P1.B20) (SEQ ID NO:20) encoding the aminoacid sequence GRG23(L3P1.B20) (SEQ ID NO:21), grg23(L3P1.B3) (SEQ IDNO:22) encoding the amino acid sequence grg23(L3P1B3) (SEQ ID NO:23);GRG23(L3P1.F18) (SEQ ID NO:24) encoding the amino acid sequenceGRG23(L3P1.F18) (SEQ ID NO:25); and, grg23(L3P1.O23) (SEQ ID NO:26)encoding the amino acid sequence GRG23(L3P1.O23) (SEQ ID NO:27).

TABLE 1 Mutations identified in glyphosate-resistant GRG23 variantsClone Amino Acid (AA) in GRG23 L3P1B20 V206-I L3P1B3 D75→H, E217→KL3P1F18 T274→I L3P1O23 R5→H

The clones were grown in 250 mL LB cultures, and protein expressioninduced isolated as described above. The purified proteins were thentested for enzymatic activity following heating for 0, 2, 4, andapproximately 16 hours at 37° C. One of the clones, termed “M5”, wasfound to retain an increased proportion of its enzymatic activity afterprolonged incubation at 37° C. (Table 2). The DNA sequence of thisclones was determined, and the gene is designated herein as grg23(ace1)(SEQ ID NO:8). The protein expressed from grg23(ace1) is designatedGRG23(ACE1) (SEQ ID NO:9).

TABLE 2 Half-life of GRG23(ACE1) vs GRG23 at elevated temperatureHalf-life at 37° C. Protein (hours) GRG23 7 GRG23(ACE1) 15.5 GRG23(ACE1)contains 2 amino acid substitutions relative to wild-type GRG23 protein:A49→T and S276→T. The pRSF1b vector that contains this gene isdesignated pAX3801. FIG. 1 shows the relative stability of GRG23 (ACE1)vs GRG23 at elevated temperatures.

Example 5 Determination of EPSPS Activity of GRG-23 Variants

Extracts containing GRG23 variant proteins were assayed for EPSPsynthase activity as described in U.S. Pat. No. 7,674,958, hereinincorporated by reference in its entirety. Assays were carried out in afinal volume of 50 ul containing 0.5 mM shikimate-3-phosphate, 200 uMphosphoenolpyruvate (PEP), 1 U/ml xanthine oxidase, 2 U/ml nucleosidephosphorylase, 2.25 mM inosine, 1 U/ml horseradish peroxidase, 2 mMglyphosate, 50 mM HEPES/KOH pH 7.0, 100 mM KCl, and AMPLEX® Red(Invitrogen) according to the manufacturer's instructions. Extracts wereincubated with all assay components except shikimate-3-phosphate for 5minutes at room temperature, and assays were started by addingshikimate-3-phosphate. EPSP synthase activity was measured using aSpectramax Gemini XPS fluorescence spectrometer (Molecular Dynamics,excitation: 555 nm; emission: 590 nm).

A full determination of kinetic parameters was performed on purifiedprotein as previously described (U.S. Pat. No. 7,674,958), adjusting forthe quantity of protein determined by Bradford assay as known in theart. For any one glyphosate concentration, EPSP synthase activity wasmeasured as a function of a broad range of PEP concentrations. The datawere fit to the Michaelis-Menten equation using KALEIDAGRAPH® software(Synergy Software) and used to determine the K_(m) (K_(m) apparent) ofthe EPSP synthase at that glyphosate concentration. K_(m) apparentvalues were determined at no fewer than four glyphosate concentrations,and the K_(i) of the EPSPS for glyphosate was calculated from the plotof K_(m) apparent vs. glyphosate concentration, using the equation(m1*x/(m2+x); m1=1; m2=1) as known in the art.

TABLE 3 Kinetics of GRG23(ACE1) vs GRG23 Km Vmax (uM) Ki (uM)(nmol/min/ug) GRG23 12.2 13,800 14.77 GRG23(ACE1) 9.7 14,620 13.73

Example 6 Identification of grg23 (ace2)

GRG23(ACE1) contains two amino acid changes relative to GRG23. Todetermine if additional substitutions at these positions could furtherimprove activity, a DNA library was generated that resulted in clonesexpressing proteins that were substantially mutated at positions 49 and276 corresponding to GRG23 (SEQ ID NO:2). Clones conferring glyphosateresistance were selected by growth on glyphosate plates, and grown andassayed for kinetic properties as described.

Surprisingly, one clone, herein designated grg23(ace2) (SEQ ID NO:10),encoding the GRG23(ACE2) protein (SEQ ID NO:11) was identified as havingimproved thermostability. The DNA sequence of grg23(ace2) shows thatGRG23(ACE2) contains a single amino acid change (residue 276 of GRG23 toarginine).

Example 7 Comparison of GRG23 and GRG51, and Mutagenesis of DifferingResidues

Two libraries were generated to assess the permutations of amino acidsequences possible from comparison of the amino acid sequences of GRG23and GRG51. The first library introduced variation from the GRG51 aminoacid sequence into a grg23(ace2) coding region. The second libraryintroduced the variation from GRG23(ACE2) amino acid sequence into thegrg51 coding region.

Clones of the resulting libraries were assessed for (1) ability toconfer glyphosate resistance upon on a cell, and (2) activity afterprolonged incubation at 37° C. A total of ten clones was sequenced andanalyzed in more detail. One particular clone, herein designated grg51.4(SEQ ID NO:12), encoding the protein GRG51.4 (SEQ ID NO:13), containsseveral amino acid changes relative to both GRG23(ACE2) and GRG51. Theamino acid changes present in GRG51.4 relative to GRG23(ACE2) weresubsequently introduced into the grg23(ace2) gene, to yield grg23(ace3)(SEQ ID NO:14), which encodes the GRG23(ACE3) protein (SEQ ID NO:15).GRG23(ACE3) exhibits superior activity and thermostability relative toGRG23, and GRG23(ACE2).

GRG23(ace1) was mutagenized, and clones were tested to identify clonesexpressing variants with improved thermostability and/or activity. Oneclone, grg23(L5P2.J2) (SEQ ID NO:16), encoding GRG23(L5P2.J2) (SEQ IDNO:17), was identified by virtue of its improved kinetic properties.GRG23(L5P2.J2) contains three amino acid changes relative to GRG23(ACE1), as shown in the following Table 4.

TABLE 4 Amino Acid changes in GRG23(L5P2.J2) Amino Acid (AA) inGRG23(L5P2.J2) relative to GRG23(ACE1) V101→F A213→6 D284→N

Oligonucleotide mutagenesis was used to modify the grg23(ace3) codingregion to contain each of the amino acid changes identified inGRG23(L5P2.J2). A clone with a gene containing these modifications wasidentified, and found to encode a protein having altered kineticproperties over GRG23(ACE3). This gene was designated grg23(ace4) (SEQID NO:18). The protein encoded by grg23(ace4) and designated asGRG23(ACE4) (SEQ ID NO:19) contains a single amino acid change relativeto GRG23(ACE3) (Valine 101 to phenylalanine). Based on this result, aseparate oligonucleotide mutagenesis was performed to test the kineticsof each possible amino acid substitution at position 101. None of theamino acid changes resulted in further improvement in kinetic propertiescompared to GRG23(ACE4). See Table 5.

TABLE 5 Kinetics of improved variants Km Ki Vmax (μM) (μM) (nmol/min/μg)GRG23 14 10,800 13 GRG51 15 21,048 13 GRG23(ACE1) 10 14,620 14GRG23(ACE2) 11 18,104 15 GRG51.4 19 26,610 17 GRG23(ACE3) 15 20,000 17GRG23(L5P2.J2) 15 2,500 23 GRG23(ACE4) 14 5,010 24

Example 8 Improved Thermostability of GRG23 Variants

The thermostability of GRG23 and several variants were determined byincubation of protein samples at 37′C for a range of times, thendetermining the residual EPSPS activity as described herein, andcomparing the activity to that of a control sample incubated at 4′C.Table 6 shows that the GRG23 variants GRG23(ACE1), GRG23(ACE2), andGRG23(ACE3) have improved thermostability.

TABLE 6 Thermostability of GRG23 and GRG23 variants Protein t_(1/2) at37° C. GRG23 10.1 GRG23(ACE1) 15.3 GRG23(ACE2) 34.2 GRG23(ACE3) 65.4

Example 9 Variants of grg23(ace3)

Oligonucleotide mutagenesis was utilized to generate variants ofgrg23(ace3) that result in expression of proteins with modifications toamino acid residues corresponding to positions 169 to 174 of SEQ IDNO:15. Mutagenesis reactions were carried out using the QuickChange® kit(Stratagene) according to the manufacturer's instructions. Plasmidclones were transformed into E. coli cell line BL21*DE3, and expressionof proteins induced by IPTG as known in the art. The proteins werepurified by affinity binding to a nickel column (TALON metal affinityresin, Clontech). The native GRG23(ace3) protein was also expressed andpurified for use as a control. Following purification of each enzyme,protein concentration was measured by Bradford assay as known in theart.

Example 10 Kinetic Analysis of GRG23(ace3) Variants

GRG23(ace3) variants GRG23(ace3) R173K (SEQ ID NO:29, encoded by SEQ IDNO:28), GRG23(ace3) G169V/L170V (SEQ ID NO:31, encoded by SEQ ID NO:30),GRG23(ace3) R173Q (SEQ ID NO:33, encoded by SEQ ID NO:32), andGRG23(ace3) I174V (SEQ ID NO:35, encoded by SEQ ID NO:34) werecharacterized by enzymatic assays as described herein, and compared tothe native GRG23(ace3) enzyme. For each enzyme the Km(app) wasdetermined at each of several glyphosate concentrations, and a plot ofKm(app) vs. glyphosate concentration was used to calculate the Ki foreach enzyme. The thermostability for each enzyme was assessed byincubating the enzyme at 37° C. for 16 hours, and then quantifying theenzymatic activity remaining (as Vmax) vs. control enzyme that wasincubated at 4° C.

Kinetic analysis reveals that GRG23(ace3)R173K, GRG23(ace3)R173Q,GRG23(ace3)I174V and GRG23(ace3)G169V/L170V are virtuallyindistinguishable from native GRG23(ace3) and show nearly identicalcatalytic rate, extremely high resistance to glyphosate, and very goodaffinity for PEP. The observed K_(m) for PEP of 19 μM for G169V/L170V(vs 15 μM for GRG23(ace3) may represent a slightly lower bindingaffinity for PEP relative to GRG23(ace3). Each of the four variants hada thermostability of greater than 95% after 16 hours at 37° C. Thekinetic values determined for the GRG23(ace3) variants GRG23(ace3)R173K, GRG23(ace3) R173Q, and GRG23(ace3) I174V are shown in Table 6.

TABLE 7 Kinetics of GRG23(ace3) variants Km (μM) Ki (mM) Vmax(nmol/min/μg) GRG23(ace3) 16 14 16 GRG23(ace3) R173K 16.6 14.7 17.7GRG23(ace3) R173Q 14.3 14.2 15.8 GRG23(ace3) I174V 15.5 15.0 15.5

Example 11 Cloning of Syngrg23 and Grg23 Variants into a PlantExpression Cassette

For syngrg23, and each of the grg23 variants described herein(including, for example, grg23(ace1), grg23(ace2), grg23(ace3),grg23(ace4), grg23(ace3)R173K, grg23(ace3)R173Q, grg23(ace3)I174V,grg23(ace3)G169V/L170V and grg23(L5P2.J2)), the open reading frame (ORF)is amplified by PCR from a full-length DNA template. Hind IIIrestriction sites are added to each end of the ORFs during PCR.Additionally, the nucleotide sequence ACC is added immediately 5′ to thestart codon of the gene to increase translational efficiency (Kozak(1987) Nucleic Acids Research 15:8125-8148; Joshi (1987) Nucleic AcidsResearch 15:6643-6653). The PCR product is cloned and sequenced usingtechniques well known in the art to ensure that no mutations areintroduced during PCR.

The plasmid containing the PCR product is digested with Hind III and thefragment containing the intact ORF is isolated. This fragment is clonedinto the Hind III site of a plasmid such as pAX200, a plant expressionvector containing the rice actin promoter (McElroy et al. (1991) Molec.Gen. Genet. 231:150-160) and the PinII terminator (An et al. (1989) ThePlant Cell 1:115-122). The promoter—gene—terminator fragment from thisintermediate plasmid is then subcloned into plasmid pSB11 (JapanTobacco, Inc.) to form a final pSB11-based plasmid. In some cases, itmay be preferable to generate an alternate construct in which achloroplast leader sequence is encoded as a fusion to the N-terminus ofthe syngrg23, grg23(ace1), grg23(ace2), grg23(ace3), grg23(ace4),grg23(L5P2.J2), grg23(ace3)R173K, grg23(ace3)R173Q, grg23(ace3)I174V, orgrg23(ace3)G169V/L170V constructs. These pSB11-based plasmids aretypically organized such that the DNA fragment containing thepromoter—gene—terminator construct, or promoter-chloroplastleader-gene-terminator construct may be excised by double digestion byrestriction enzymes, such as Kpn I and Pme I, and used fortransformation into plants by aerosol beam injection. The structure ofthe resulting pSB11-based clones is verified by restriction digest andgel electrophoresis, and by sequencing across the various cloningjunctions.

The plasmid is mobilized into Agrobacterium tumefaciens strain LBA4404which also harbors the plasmid pSB1 (Japan Tobacco, Inc.), usingtriparental mating procedures well known in the art, and plating onmedia containing spectinomycin. The pSB11-based plasmid clone carriesspectinomycin resistance but is a narrow host range plasmid and cannotreplicate in Agrobacterium. Spectinomycin resistant colonies arise whenpSB11-based plasmids integrate into the broad host range plasmid pSB1through homologous recombination. The cointegrate product of pSB1 andthe pSB11-based plasmid is verified by Southern hybridization. TheAgrobacterium strain harboring the cointegrate is used to transformmaize by methods known in the art, such as, for example, the PureIntromethod (Japan Tobacco).

Example 12 Transformation of Plant Cells by Agrobacterium-MediatedTransformation

Maize ears are best collected 8-12 days after pollination. Embryos areisolated from the ears, and those embryos 0.8-1.5 mm in size arepreferred for use in transformation. Embryos are plated scutellumside-up on a suitable incubation media, such as DN62A5S media (3.98 g/LN6 Salts; 1 ml/L (of 1000× Stock) N6 Vitamins; 800 mg/L L-Asparagine;100 mg/L Myo-inositol; 1.4 g/L L-Proline; 100 mg/L Casamino acids; 50g/L sucrose; 1 ml/L (of 1 mg/ml stock) 2,4-D). However, media and saltsother than DN62A5S are suitable and are known in the art. Embryos areincubated overnight at 25° C. in the dark. However, it is not necessaryper se to incubate the embryos overnight.

The resulting explants are transferred to mesh squares (30-40 perplate), transferred onto osmotic media for about 30-45 minutes, thentransferred to a beaming plate (see, for example, PCT Publication No.WO/0138514 and U.S. Pat. No. 5,240,842).

DNA constructs designed to express the GRG proteins of the presentinvention in plant cells are accelerated into plant tissue using anaerosol beam accelerator, using conditions essentially as described inPCT Publication No. WO/0138514. After beaming, embryos are incubated forabout 30 min on osmotic media, and placed onto incubation mediaovernight at 25° C. in the dark. To avoid unduly damaging beamedexplants, they are incubated for at least 24 hours prior to transfer torecovery media. Embryos are then spread onto recovery period media, forabout 5 days, 25° C. in the dark, then transferred to a selection media.Explants are incubated in selection media for up to eight weeks,depending on the nature and characteristics of the particular selectionutilized. After the selection period, the resulting callus istransferred to embryo maturation media, until the formation of maturesomatic embryos is observed. The resulting mature somatic embryos arethen placed under low light, and the process of regeneration isinitiated by methods known in the art. The resulting shoots are allowedto root on rooting media, and the resulting plants are transferred tonursery pots and propagated as transgenic plants.

Materials DN62A5S Media

Components per liter Source Chu's N6 Basal Salt 3.98 g/L PhytotechnologyLabs Mixture (Prod. No. C 416) Chu's N6 Vitamin 1 ml/L PhytotechnologyLabs Solution (Prod. No. (of 1000x Stock) C 149) L-Asparagine 800 mg/LPhytotechnology Labs Myo-inositol 100 mg/L Sigma L-Proline 1.4 g/LPhytotechnology Labs Casamino acids 100 mg/L Fisher Scientific Sucrose50 g/L Phytotechnology Labs 2,4-D (Prod. No. 1 ml/L Sigma D-7299) (of 1mg/ml Stock)

Adjust the pH of the solution to pH 5.8 with 1N KOH/1N KCl, add Gelrite(Sigma) to 3 g/L, and autoclave. After cooling to 50° C., add 2 ml/L ofa 5 mg/ml stock solution of Silver Nitrate (Phytotechnology Labs).Recipe yields about 20 plates.

Example 13 Transformation of EPSP synthase enzymes into Maize PlantCells by Agrobacterium-Mediated Transformation

Ears are best collected 8-12 days after pollination. Embryos areisolated from the ears, and those embryos 0.8-1.5 mm in size arepreferred for use in transformation. Embryos are plated scutellumside-up on a suitable incubation media, and incubated overnight at 25°C. in the dark.

However, it is not necessary per se to incubate the embryos overnight.Embryos are contacted with an Agrobacterium strain containing theappropriate vectors having an EPSP synthase enzyme of the presentinvention for Ti plasmid mediated transfer for about 5-10 min, and thenplated onto co-cultivation media for about 3 days (25° C. in the dark).After co-cultivation, explants are transferred to recovery period mediafor about five days (at 25° C. in the dark). Explants are incubated inselection media for up to eight weeks, depending on the nature andcharacteristics of the particular selection utilized. After theselection period, the resulting callus is transferred to embryomaturation media, until the formation of mature somatic embryos isobserved. The resulting mature somatic embryos are then placed under lowlight, and the process of regeneration is initiated as known in the art.The resulting shoots are allowed to root on rooting media, and theresulting plants are transferred to nursery pots and propagated astransgenic plants.

All publications and patent applications mentioned in the specificationare indicative of the level of skill of those skilled in the art towhich this invention pertains. All publications and patent applicationsare herein incorporated by reference to the same extent as if eachindividual publication or patent application was specifically andindividually indicated to be incorporated by reference.

Although the foregoing invention has been described in some detail byway of illustration and example for purposes of clarity ofunderstanding, it will be obvious that certain changes and modificationsmay be practiced within the scope of the appended claims.

That which is claimed:
 1. An isolated nucleic acid molecule selectedfrom the group consisting of: a) a nucleic acid molecule comprising thenucleotide sequence of SEQ ID NO:28; and, b) a nucleic acid moleculewhich encodes a polypeptide comprising the amino acid sequence of SEQ IDNO:29.
 2. The isolated nucleic acid molecule of claim 1, wherein saidnucleotide sequence is a synthetic sequence that has been designed forexpression in a plant.
 3. A vector comprising the nucleic acid moleculeof claim
 1. 4. The vector of claim 3, further comprising a nucleic acidmolecule encoding a heterologous polypeptide.
 5. A host cell thatcontains the vector of claim
 3. 6. The host cell of claim 5 that is abacterial host cell.
 7. The host cell of claim 5 that is a plant cell.8. A transgenic plant comprising the host cell of claim
 7. 9. The plantof claim 8, wherein said plant is selected from the group consisting ofmaize, sorghum, wheat, sunflower, tomato, crucifers, peppers, potato,cotton, rice, soybean, sugarbeet, sugarcane, tobacco, barley, andoilseed rape.
 10. A transgenic seed comprising the nucleic acid moleculeof claim
 1. 11. An isolated polypeptide selected from the groupconsisting of: a) a polypeptide comprising the amino acid sequence ofSEQ ID NO:29; and, b) a polypeptide encoded by the nucleotide sequenceof SEQ ID NO: SEQ ID NO:28.
 12. The polypeptide of claim 11 furthercomprising a heterologous amino acid sequence.
 13. A method forproducing a polypeptide with herbicide resistance activity, comprisingculturing the host cell of claim 5 under conditions in which a nucleicacid molecule encoding the polypeptide is expressed, said polypeptidebeing selected from the group consisting of: a) a polypeptide comprisingthe amino acid sequence of SEQ ID NO:29; and, b) a polypeptide encodedby the nucleotide sequence of SEQ ID NO: SEQ ID NO:28.
 14. A method forconferring resistance to an herbicide in a plant, said method comprisingtransforming said plant with a DNA construct, said construct comprisinga promoter that drives expression in a plant cell operably linked with anucleotide sequence selected from the group consisting of SEQ ID NO:28,and regenerating a transformed plant.
 15. The method of claim 14,wherein said herbicide is glyphosate.
 16. A plant having stablyincorporated into its genome a DNA construct comprising a nucleotidesequence that encodes a protein having herbicide resistance activity,wherein said nucleotide sequence is selected from the group consistingof: a) a nucleic acid molecule comprising the nucleotide sequence of SEQID NO:28; and, b) a nucleic acid molecule which encodes a polypeptidecomprising the amino acid sequence of SEQ ID NO:29; wherein saidnucleotide sequence is operably linked to a promoter that drivesexpression of a coding sequence in a plant cell.
 17. The plant of claim16, wherein said plant is a plant cell.
 18. The plant of claim 16,wherein said plant is a soybean plant.
 19. The plant of claim 16,wherein said plant is a corn plant.
 20. The plant of claim 16, whereinsaid plant is selected from the group consisting of maize, sorghum,wheat, sunflower, tomato, crucifers, peppers, potato, cotton, rice,soybean, sugarbeet, sugarcane, tobacco, barley, and oilseed rape.
 21. Amethod for increasing vigor or yield in a plant comprising: a)introducing into said plant the nucleotide sequence set forth in SEQ IDNO:28, 8, 10, 14, 30, 32, or 34; b) contacting said plant with aneffective concentration of glyphosate; and, c) growing said plant underconditions wherein the temperature is higher than ambient environmentaltemperature for at least two consecutive hours per day for at least fourdays following contact with said glyphosate, wherein said days followingcontact is within the growing season of the plant, wherein the vigor oryield of said plant is higher than the vigor or yield of a plantexpressing a glyphosate tolerance EPSP synthase that does not have atemperature optimum higher than ambient environmental temperature. 22.The method of claim 21, wherein the temperature in step (c) is about 32°C. to about 60° C.
 23. A method for conferring resistance to glyphosatein a plant comprising: a) introducing into said plant the nucleotidesequence set forth in SEQ ID NO:28, 8, 10, 14, 30, 32, or 34; b)contacting said plant with an effective concentration of glyphosate;and, c) growing said plant under conditions wherein the temperature ishigher than ambient environmental temperature for at least twoconsecutive hours per day for at least four days following contact withsaid glyphosate, wherein said days following contact is within thegrowing season of the plant.
 24. The method of claim 23, wherein thetemperature in step (c) is about 32° C. to about 60° C.
 25. The methodof claim 24, wherein the temperature in step (b) is about 37° C.